HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAsafety guidance72% confidence

Over-The-Counter (OTC) Heartburn Treatment

Source: FDA

Why This Matters

Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as Veterans with Opioid Use Disorder.

Regulatory Analysis

There are three classes of OTC medications for the treatment of heartburn. Learn more.

Supporting Context

Therapeutic area
Substance Use Disorder · Opioid Use Disorder
Sub-indication
Pain

Related signal: VA Study to Test Values-Based Intervention for Veterans in Buprenorphine Treatment

Source

View source document

Related Signal

Open signal — VA Study to Test Values-Based Intervention for Veterans in Buprenorphine Treatment
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.